The effect of sitagliptin or alogliptin on blood glucose levels and vascular endothelial function in type2 diabetes
Not Applicable
- Conditions
- type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000011117
- Lead Sponsor
- Fukuoka Tokushukai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1)Serum creatine levels are 1.5mg/dL (male)and 1.3mg/dL(female) or more. 2)Patients with taking glinides or GLP-1 3) Patients sufferd from severe ketosis, diabetic coma or semi-coma within 6- month before participating the study 4) Patients sufferd from severe infection or trauma, and perioperative 5)Possible or definitive pregnant women or nursing mother 6) Patients with history of hypersensitivity to any ingredients of sitagliptin and alogliptin tablets 7)Patients with taking DPP-4 Inhibitor Other patients deemed not appropliate for participating to the study by investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change of HbA1c levels and rate
- Secondary Outcome Measures
Name Time Method